Hyperfine, Inc. (NASDAQ:HYPR)
| Market Cap | $49.73M-48.0% |
| Revenue (ttm) | $19.06M+80.0% |
| Net Income | -$29.81M+25.6% |
| EPS | -$0.30+41.8% |
| Shares Out | 90.99M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,239,541 |
| Open | $0.53 |
| Previous Close | $0.52 |
| Day's Range | $0.49 - $0.55 |
| 52-Week Range | $0.49 - $1.94 |
| Beta | 1.50 |
| Analysts | Buy |
| Price Target | $1.80(+229.37%) |
| Earnings Date | Mar 17, 2027 |
About HYPR
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, and New Zealand. The company was founded in 2014 and is based in Guilford, Connecticut.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
1 firm rating HYPR in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Mar 17, 2027Earnings report
$HYPR stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in HYPR holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by HYPR's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
HYPR Estimated quarterly lobbying spending
Source: U.S. Senate LDA
HYPR Revenue by Segment
| Device | $5.24M | 87.97% |
| Service | $717.00K | 12.03% |
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New HYPR patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to HYPR from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in HYPR
| VTIVanguard Morningstar Total Stock Market ETF | $1.32M |
| IWMiShares Russell 2000 ETF | $891.42K |
| VXFVanguard Extended Market ETF | $674.32K |
| IWOiShares Russell 2000 Growth ETF | $390.73K |
| VTWOVanguard Russell 2000 ETF | $326.09K |
| IWCiShares Micro-Cap ETF | $124.60K |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from HYPR’s recent data — informational, not investment advice
What’s Behind the Score
News check: Q3 2026 results featured record revenue with 73% growth; company presenting at major healthcare conference signals momentum.
Recent Insider Activity
Insider Score Trend Over Time
-51.0 since Aug 26Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
Frequently Asked Questions
ETFs that hold this stock
| BUSM | EA Series Trust - EA Bridgeway Ultra-Small Company Market ETF | 0.05% |
Weight is the stock’s share of each fund’s holdings.
